You are here: Industry Insights > NHS

News List

NICE rejects Lilly’s breast cancer drug Verzenios pharmatimes
November 01, 2018
As it stands Eli Lilly’s Verzenios will not be routinely funded on the NHS for breast cancer, as cost-regulators have now issued draft guidelines rejecting the drug.
Accelerated Access Collaborative announces first Rapid Uptake Products for NHS pharmatimes
October 25, 2018
Tthe Accelerated Access Collaborative (AAC) has announced that Roche Diagnostics tests for suspected pre-eclampsia and heart attack have been recognised as ‘transformative’ ...
Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug pharmafile
October 19, 2018
Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning groups (CCGs) decision to use a cheaper...
Gov’t to introduce tech standards for the NHS pharmatimes
October 19, 2018
Health secretary Matt Hancock has unveiled his vision for technology in healthcare, which, he claims, will lay the foundation for a new generation of digital services able to meet the needs of clinicians, patients and managers.
NHS England widens GP recruitment drive to Australia pharmatimes
October 11, 2018
NHS England is targeting Australia in its latest drive to boost GP numbers.
NHS England reaches deal with Gilead on CAR-T therapy Yescarta pharmaceutical-technology
October 09, 2018
National Health Service (NHS) England has reached an agreement with Gilead Sciences to provide the pharmaceutical company’s chimeric antigen receptor T-cell (CAR-T) therapy Yescarta (axicabtagene ciloleucel) for adults with large cell lymphoma.
Public inquiry investigates thousands of deaths from infected NHS blood pharmaphorum
September 27, 2018
A public inquiry has opened to look into how infected NHS blood killed more than 2,900 people since the 1970s.
Patients call for end to CF drug price row at key meeting pharmaphorum
September 27, 2018
Representatives of NHS England and cystic fibrosis drug company Vertex are to meet on Thursday to try and resolve a two-year impasse over access to life-changing medications.
English court backs NHS in fight with Bayer, Novartis over off-label Avastin use fiercepharma
September 25, 2018
After a long legal fight with Bayer and Novartis, England’s National Health Service has won the right to use a compounded form of Roche’s Avastin off-label in patients with wet age-related macular degeneration over much ...
A&E attendances in England leap 22% in a decade pharmatimes
September 18, 2018
The number of people visiting A&E in England has jumped by more than one-fifth in ten years, official figures show.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page